Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPSE | Q9Y251 | 10/20 | 0.61 |
| ▸ | FGF1 | P05230 | 7/20 | 0.61 |
| ▸ | FGF2 | P09038 | 7/20 | 0.61 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.52 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.48 |
| ▸ | ST3GAL1 | Q11201 | 1/20 | 0.48 |
| ▸ | POLA1 | P09884 | 1/20 | 0.47 |
| ▸ | CDC25A | P30304 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3691749 | 0.89 | HPSE (0.68) | HPSEFGF1FGF2NR1H4ST3GAL1 | |
| SCHEMBL23601690 | 0.87 | POLB (0.56) | HPSEFGF1FGF2LGALS3POLA1 | |
| SCHEMBL23601842 | 0.87 | POLB (0.56) | HPSEFGF1FGF2LGALS3POLA1 | |
| SCHEMBL21340577 | 0.83 | HPSE (0.65) | HPSEFGF1FGF2ST3GAL1POLA1 | |
| SCHEMBL23223301 | 0.81 | HPSE (0.63) | HPSEFGF1FGF2ST3GAL1POLA1 | |
| SCHEMBL23223299 | 0.81 | HPSE (0.63) | HPSEFGF1FGF2ST3GAL1POLA1 | |
| SCHEMBL24017722 | 0.81 | CDC25A (0.60) | HPSEFGF1FGF2ST3GAL1POLA1 | |
| SCHEMBL24017768 | 0.80 | HPSE (0.61) | HPSEFGF1FGF2ST3GAL1POLA1 | |
| SCHEMBL21340483 | 0.80 | HPSE (0.61) | HPSEFGF1FGF2ST3GAL1POLA1 | |
| SCHEMBL20004930 | 0.79 | CDC25A (0.61) | HPSEFGF1FGF2ST3GAL1POLA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3845249-A1 | TARGETED NANOPREPARATION OF MANNOSE, AND PREPARATION THEREFOR AND APPLICATION THEREOF | Chengdu Ribocure Pharmatech Company Limited (CN) | 2021-07-07 | — | — | EP | disclosed |